icumed.com (ICUI): Rentabilitas operasi

ICU Medical, Inc. (ICUI) - logo korporat

ICU Medical, Inc. (ICUI) is considered a benchmark in critical care medicine due to the high level of physician trust in the safety of its systems. The target operating margin allows for an assessment of current efficiency, with the parameter stabilizing at 8.00. Management is currently focusing on restoring profitability and logistics. Looking ahead, ICU Medical, Inc. (ICUI) plans to become a global leader in infusion therapy through the integration of smart pumps.

ICUI - Rasio bathi operasi ICU Medical ing rentang 04.07.2022 - 19.11.2026

ICUI (ICU Medical, Inc.): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis komprehensif perusahaan:ICU Medical Inc
Produk dadi ICU Medical Inc.

Operating margin reflects cost management efficiency, representing the share of operating profit in total revenue before financial expenses and taxes. By analyzing changes in operating margin, an investor assesses the resilience of the ICU Medical, Inc. (ICUI) business model within the mature infusion therapy market, where stable hospital demand allows the company to maintain profitability while updating its technological product lines.

Pesaing utama

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Rentabilitas dodolan operasi Dentsply Sirona Inc XRAY|Rentabilitas operasi LeMaitre Corp (LMAT)|ATRC (AtriCure Corp) - Tingkat bathi operasi|Margin operasi STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Rentabilitas dodolan operasi|ZimVie Inc - Margin operasi|Rentabilitas dodolan operasi AngioDynamics|CERS (Cerus Corp) - Margin dodolan operasi|Alpha Teknova, Inc. - Tingkat bathi operasi|MGRM (Monogram Orthopedics Inc.) - Margin operasi|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi